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INTRODUCTION
Mammalian erythroblasts proliferate, differentiate and enucleate within specialized microenvironmental niches, termed erythroblastic islands [1, 2, 3, 4] . Since we are approaching the 50 th anniversary of the first description of erythroblastic islands by Dr. Marcel Bessis, it seems timely to focus a review on our current knowledge of the molecular characterization and functions of these compartments dedicated to terminal erythroid differentiation. Fetal liver, bone marrow and splenic erythropoiesis occur within erythroblastic islands, composed of developing erythroblasts surrounding a central macrophage ( Figure 1 ) [2] . Areas of erythropoiesis in long term bone marrow cultures also contain central macrophages [1] . Reconstruction of 3-dimensional models of bone marrow from serial sections show that islands are distributed over the entire marrow space and not localized to specific regions [4] . Although early electron microscopic analysis of thin sections suggest that central macrophages phagocytose extruded nuclei and supply iron to developing erythroblasts [5] , the role of central macrophages in iron
metabolism is yet to be clearly delineated. Extensive cell-cell interactions, both erythroblastmacrophage, as well as erythroblast-erythroblast occur within islands and, to date, several specific intercellular adhesive interactions have been defined. Although our current understanding of molecular mechanisms operating within islands is at an early stage, tantalizing evidence suggests that erythroblastic islands are highly specialized hematopoietic tissue subcompartments where intercellular interactions in concert with stimulatory and inhibitory cytokines play critical roles in regulating erythropoiesis and apoptosis.
CELLULAR COMPOSITION AND STRUCTURE OF ISLANDS
During steady state erythropoiesis, erythroblastic islands are composed of erythroid cells at various stages of differentiation from CFU-E through young, multilobulated reticulocytes [6, 7, 8, 9, 10] . In the unstressed state there also appears to be variation in the number of cells per island. Tissue sections from rat femur reveal about 10 cells per island [10] while islands harvested from human marrow contain 5->30 erythroblasts per island [8] . [11, 12, 13] .
Forssman glycosphingolipid distinguishes central macrophages from monocytes and from bone marrow macrophages cultured with macrophage colony-stimulating factor (M-CSF) [14, 15, 16] .
Immunophenotyping of central macrophages harvested from human bone marrow islands shows expression of FcRI, FcRII, FcRIII, CD4, CD31, CD11a, CD11c, CD18, CD31 and HLA-DR [8] .
Erythroblastic islands are present in mammalian bone marrow and in splenic red pulp in certain species, such as mouse. In mouse fetal liver, definitive erythropoiesis also occurs in islands [17] but the question of whether primitive erythropoiesis does remains unanswered. In contrast to definitive erythropoiesis, primitive erythroblasts are released into circulation as nucleated red cells and undergo enucleation while in circulation [18] . If the central macrophage has a functional role in enucleation of definitive fetal-, bone marrow-and splenic-derived erythroblasts, the observation that primitive erythroblasts do not enucleate during differentiation in the liver argues that they may not differentiate within islands. In support of this speculation is a report showing that mature avian red cells, that remain nucleated, differentiate in bone marrow that does not contain islands [19] . [30] ) certain of these receptor-counterreceptor interactions may trigger signaling pathways coordinating adhesion and gene expression.
CELL-CELL ADHESION

REGULATORY FEEDBACK WITHIN ISLANDS
It is appealing to speculate that erythropoiesis is driven by both positive and negative regulatory feedback mechanisms operating within islands. Erythroblasts differentiating in vivo or in vitro secrete two angiogenic factors, vascular endothelial growth factor A (VEGF-A) and placenta growth factor (PIGF) [33] . Media from cultured erythroblasts induces migration of monocytes and endothelial cell permeability, both inhibited by VEGF-A and PIGF specific antibodies. Since erythroid progenitors do not express receptors for either of these angiogenic factors, the secreted molecules may function as paracrine effectors, mediating crosstalk between erythroblasts and receptor-expressing macrophages that regulates island structure. Additionally, the angiogenic factors may enable reticulocyte marrow egress by affecting endothelial cell junctional integrity.
The transcription factor GATA-1 is crucial for erythropoiesis. Absence of GATA-1 expression results in proerythroblast apoptosis [34, 35, 36, 37] and is embryonic lethal in knockout mice [38] whereas overexpression of GATA-1 blocks terminal differentiation [39, 40] .
Strikingly, the presence of normally expressing cells enables GATA-1 overexpressing cells to complete normal terminal differentiation. Using a mouse model in which half of the mouse red cells are null for GATA-1 and half overexpress GATA-1 it has been observed that normal late stage erythroblasts produce a signal, termed REDS (red cell differentiation signal) that corrects the flaw(s) in GATA-1 overexpressing cells [41*] . Mechanistically this appears to involve cellcell interaction rather than a soluble factor, underscoring the importance of intercellular signaling between erythroblasts in regulating GATA-1 activity and gene expression.
CENTRAL MACROPHAGE FUNCTION
What key functions do central macrophages perform in addition to providing adhesive interactions? It has long been recognized that they phagocytose extruded erythroblast nuclei at the conclusion of terminal differentiation [42, 43, 44] . In the fetal liver expelled nuclei rapidly [56] . Despite these observations, controversy exists as to whether the RB null defect is erythroblast intrinsic or extrinsic; indeed, there is some evidence that it may be both [17] . Rb null erythroblasts do not differentiate normally in vitro [53] , and do not undergo cell cycle exit or enucleation normally, thus supporting an additional, intrinsic erythroblast defect [57] . Further investigations will be required to clarify these issues.
LOCALIZATION OF ISLANDS
Erythroblastic islands are distributed throughout the marrow, including regions adjacent to sinusoids through which reticulocytes enter the circulation. A tantalizing question is whether islands are mobile structures and migrate toward sinusoids. Using quantitative light and electron microscopy of rat bone marrow, the differentiation stage of erythroblasts in 40 islands adjacent to sinusoids and 40 islands nonadjacent has been compared [58] . Islands in all locations contain similar numbers of basophilic and polychromatophilic erythroblasts. However, there are significantly more proerythroblasts in nonadjacent islands and significantly more acidophilic cells in islands neighboring sinusoids, clearly suggesting that erythroblastic islands may migrate to sinusoids as the cells within the island become more differentiated. If these observations are confirmed one could speculate that crosstalk between developing erythroblasts and the central macrophage could stimulate macrophage secretion of proteases that remodel underlying extracellular matrix and enable islands to be released from their original site of matrix attachments.
CONCLUSION
and intracellular signaling operating within erythroblastic islands is in an early stage. Current information opens up many exciting new avenues for exploration and it is hoped that before the 75 th anniversary of the first description of erythroblastic islands we will have a much clearer understanding of molecular mechanisms crucial for normal terminal erythroid differentiation which occur within these remarkable microenvironmental niches.
